Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 119.7 | 91.2 | 51.6 |
| Revenue growth | 31.3% | 76.7% | |
| Cost of goods sold | 158.8 | 278.0 | 70.6 |
| Gross profit | -39.1 | -186.8 | -19.0 |
| Gross margin | -32.7% | -204.8% | -36.8% |
| Sales and marketing | 101.8 | 95.0 | 69.4 |
| Research and development | 57.5 | 36.2 | 18.0 |
| General and administrative | 71.5 | 49.2 | 36.8 |
| EBITA | -273.8 | -408.9 | -140.6 |
| EBITA margin | -228.7% | -448.4% | -272.5% |
| Amortization of intangibles | 5.3 | 5.7 | 3.7 |
| EBIT | -279.1 | -414.6 | -144.3 |
| EBIT margin | -233.2% | -454.6% | -279.7% |
| Pre-tax income | -325.2 | -367.2 | -143.2 |
| Income taxes | 1.3 | 0.7 | -1.8 |
| Tax rate | | | 1.3% |
| Net income | -333.4 | -371.4 | -141.5 |
| Net margin | -278.5% | -407.2% | -274.2% |
| |
| Diluted EPS | ($14.66) | ($34.11) | ($1.63) |
| Shares outstanding (diluted) | 22.7 | 10.9 | 86.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|